
Pfizer's child-sized vaccine fails to produce expected immunity in younger kids; company adds third dose to trials
CNN
Vaccine maker Pfizer said Friday that trials of its vaccine in children ages 2 to 5 show it did not provide the expected immunity in kids this age and it is adding a third dose to the regimen.
The company decided to add the third dose for all children and babies ages 6 months to 5 years after its independent outside advisers took a look at the data so far.
It showed that two child-sized doses of the Pfizer/BioNtech vaccine was not producing the expected immunity in the 2- to 5-year-olds, although it was doing so for the babies up to age 2.

The two men killed as they floated holding onto their capsized boat in a secondary strike against a suspected drug vessel in early September did not appear to have radio or other communications devices, the top military official overseeing the strike told lawmakers on Thursday, according to two sources with direct knowledge of his congressional briefings.












